Skip to main content
. 2019 Mar 8;11(1):1586421. doi: 10.1080/20002297.2019.1586421

Table 2.

HNC patients, paired oral samples, and longitudinal PERMANOVA analyses.

Longitudinal Analysis
T0-Tx
Patient Count (M/F) Patient %M/F Paired Samples PERMANOVA Time: All Probes* PERMANOVA Time: Caries Probes**
Set-1 [T0-T6] 31 (26/5) 84/16 101 0.0001 0.0001
Set-1 [T0-T18] 23 (19/4) 83/17 69 0.0003 0.0001
Set-2 [T0-T6] 22 (18/4) 82/18 60 0.0002 0.0004
Set-2 [T0-T18] 22 (18/4) 82/18 60 0.0005 0.0003
Subset-A [T0-T6] 28 (23/5) 82/18 90 0.0001 0.0001
Subset-A [T0-T18] 20 (16/4) 80/20 58 0.0002 0.0001
Subset-B [T0-T6] 20 (16/4) 80/20 63 0.0001 0.0001
Subset-B [T0-T18] 14 (11/3) 79/21 39 0.0038 0.0033
Subset-C [T0-T6] 21 (17/4) 81/19 66 0.0001 0.0001
Subset-C [T0-T18] 14 (11/3) 79/21 38 0.0017 0.0007
Subset-D [T0-T6] 24 (20/4) 83/17 79 0.0001 0.0001
Subset-D [T0-T18] 19 (15/4) 79/21 55 0.0001 0.0001

Longitudinal multivariate permutational analyses of variance (PERMANOVA) were performed on square root transformed relative abundance data. Monte-Carlo corrected p-values for the fixed variable ‘Time’ are shown with alpha level of significance level set at 0.01.

Set-1: all patients with and without DMFS score information

Set-2: all patients samples in common across the three timepoints T0, T6, and T18, with and without DMFS score information.

Set-1 subsets of patients with DMFS score information: Subset-A (all patients), Subset-B (all patients who did not receive induction chemotherapy), Subset-C (all patients who did not receive antibiotics within 2 weeks of sampling), Subset-D (all patients who received concurrent chemotherapy).

T0 to Tx: baseline to 6-months post-RT sampling (T0-T6), or baseline to 18-months post-RT sampling (T0-T18).

Gender: M (male), F (female).

*Species probes (n = 638) plus genus probes (n = 129); **probes for caries-associated species (n = 45).